Guangzhou Vesber Biotechnology Co., Ltd. is a national high-tech enterprise focusing on R & D, production and sales of ophthalmic innovative products. The main products include foldable artificial vitreous balloon, myopia posterior sclera reinforcement system and periocular drug delivery system. Among them, the representative product, the foldable artificial vitreous balloon (fcvb), is the first artificial organ to save the eyeball in the world, which can finely simulate the structure and function of the vitreous body of the human eye. It was included in the medical device innovation product catalog of the Ministry of science and technology of the people’s Republic of China in 2018. In the review of the 40th anniversary of the reform and opening up of the State Food and drug administration, it was listed as a typical example of “made in China” to “created in China”. The product has also been funded by the 863 project of the Ministry of science and technology and the 12th Five year science and technology support plan, and has 22 patents in China, the United States, Russia, Australia, Japan, etc.